Implications of oral Helicobacter pylori for the outcome of its gastric eradication therapy

Journal of Clinical Gastroenterology

Volumn 41, Issue 2, 2007, Pages 145-151

  Czesnikiewicz Guzik, Marta ^a,c   Loster, Bartłomiej ^a   Bielanski, Wladyslaw ^a   Guzik, Tomasz J ^a,c   Konturek, Peter C ^b   Zapala, Jan ^a   Konturek, Stanisław J ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastrin; Ghrelin; Helicobacter pylori; Oral cavity; RAPD; Stomach

Indexed keywords

AMOXICILLIN; BACTERIAL DNA; BACTERIUM ANTIBODY; CLARITHROMYCIN; GASTRIN; GHRELIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; OMEPRAZOLE; PEPSINOGEN I;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIBODY DETECTION; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DYSPEPSIA; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL INFECTION; GASTROSCOPY; GINGIVITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; MOUTH CAVITY; MOUTH INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RANDOM AMPLIFIED POLYMORPHIC DNA; SALIVA ANALYSIS; SCREENING; STOMACH BIOPSY; TREATMENT OUTCOME; UREA BREATH TEST;

ADULT; AGED; AGED, 80 AND OVER; DNA, BACTERIAL; FEMALE; GASTRINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MIDDLE AGED; MOUTH; PEPSINOGEN A; PEPTIDE HORMONES; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; STOMACH; TREATMENT OUTCOME;

EID: 33846462078     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000225654.85060.3d     Document Type: Article

References (43)

1. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347:1175-1186.
2. Israel DA, Peek RM Jr. The role of persistence in Helicobacter pylori pathogenesis. Curr Opin Gastroenterol. 2006;22:3-7.
3. Konturek PC, Konturek SJ, Starzyska T, et al. Helicobacter pylori- gastrin link in MALT lymphoma. Aliment Pharmacol Ther. 2000;14:1311-1318.
4. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke. 2003;34:2518-2532.
5. Georges JL, Rupprecht HJ, Blankenberg S, et al. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol. 2003;92:515-521.
6. Pieniazek P, Karczewska E, Duda A, et al. Association of Helicobacter pylori infection with coronary heart disease. J Physiol Pharmacol. 1999;50:743-751.
7. Argenziano G, Donnarumma G, Iovene MR, et al. Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients. Int J Dermatol. 2003;42:601-604.
8. Moreira A, Rodrigues J, Delgado L, et al. Is Helicobacter pylori infection associated with chronic idiopathic urticaria? Allergol Immunopathol (Madr). 2003;31:209-214.
9. Takahashi T, Yujiri T, Shinohara K, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2004;124:91-96.
10. Bravo LE, Mera R, Reina JC, et al. Impact of Helicobacter pylori infection on growth of children: a prospective cohort study. J Pediatr Gastroenterol Nutr. 2003;37:614-619.
11. Konturek SJ, Konturek PC, Brzozowski T, et al. From nerves and hormones to bacteria in the stomach; Nobel prize for achievements in gastrology during last century. J Physiol Pharmacol 2005;56:507-530.
12. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002;16:167-180.
13. Lara LF, Cisneros G, Gurney M, et al. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection. Arch Intern Med. 2003;163:2079-2084.
14. Zullo A, Vaira D, Vakil N, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther. 2003;17:719-726.
15. Kamiji MM, de Oliveira RB. Non-antibiotic therapies for Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2005;17: 973-981.
16. Karczewska E, Konturek JE, Konturek PC, et al. Oral cavity as a potential source of gastric reinfection by Helicobacter pylori. Dig Dis Sci. 2002;47:978-986.
17. Dowsett SA, Archila L, Segreto VA, et al. Helicobacter pylori infection in indigenous families of Central America: serostatus and oral and fingernail carriage. J Clin Microbiol. 1999;37:2456-2460.
18. Riggio MP, Lennon A. Identification by PCR of Helicobacter pylori in subgingival plaque of adult periodontitis patients. J Med Microbiol. 1999;48:317-322.
19. Cammarota G, Tursi A, Montalto M, et al. Role of dental plaque in the transmission of Helicobacter pylori infection. J Clin Gastroenterol. 1996;22:174-177.
20. Oshowo A, Gillam D, Botha A, et al. Helicobacter pylori: the mouth, stomach, and gut axis. Ann Periodontol. 1998;3:276-280.
21. Siddiq M, Haseeb ur R, Mahmood A. Evidence of Helicobacter pylori infection in dental plaque and gastric mucosa. J Coll Physicians Surg Pak. 2004;14:205-207.
22. Okuda K, Ishihara K, Miura T, et al. Helicobacter pylori may have only a transient presence in the oral cavity and on the surface of oral cancer. Microbiol Immunol. 2000;44:385-388.
23. Song Q, Spahr A, Schmid RM, et al. Helicobacter pylori in the oral cavity: high prevalence and great DNA diversity. Dig Dis Sci. 2000;45:2162-2167.
24. Czesnikiewicz-Guzik M, Karczewska E, Bielanski W, et al. Association of the presence the Helicobacter pylori in the oral cavity and in the stomach. J Physiol Pharmacol. 2004;55(suppl 2):105-115.
25. Rembiasz K, Konturek PC, Karcz D, et al. Biomarkers in various types of atrophic gastritis and their diagnostic usefulness. Dig Dis Sci. 2005;50:474-482.
26. Płonka M, Bielanski W, Konturek SJ, et al. Helicobacter pylori infection and serum gastrin, ghrelin and leptin in children of Polish shepherds. Dis Liver Dis. 2006; 8:91-97.
27. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on Histopathology of Gastritis. Houston 1994. Am J Surg Pathol. 1996;20:1161-1181.
28. Megraud F, Lamouliatte H. Review article: the treatment of refractory Helicobacter pylori infection. Aliment Pharmacol Ther. 2003;17:1333-1343.
29. Kim N, Lim SH, Lee KH, et al. Helicobacter pylori in dental plaque and saliva. Korean J Intern Med. 2000;15:187-194.
30. Namavar F, Roosendaal R, Kuipers EJ, et al. Presence of Helicobacter pylori in the oral cavity, oesophagus, stomach and faeces of patients with gastritis. Eur J Clin Microbiol Infect Dis. 1995;14:234-237.
31. Nguyen AM, Engstrand L, Genta RM, et al. Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reaction. J Clin Microbiol. 1993;31:783-787.
32. Song Q, Lange T, Spahr A, et al. Characteristic distribution pattern of Helicobacter pylori in dental plaque and saliva detected with nested PCR. J Med Microbiol. 2000;49:349-353.
33. Kasuga Y, Ikenoya H, Okuda K. Bactericidal effects of mouth rinses on oral bacteria. Bull Tokyo Dent Coll. 1997;38:297-302.
34. Okuda K, Adachi M, Iijima K. The efficacy of antimicrobial mouth rinses in oral health care. Bull Tokyo Dent Coll. 1998;39:7-14.
35. Miyabayashi H, Furihata K, Shimizu T, et al. Influence of oral Helicobacter pylori on the success of eradication therapy against gastric Helicobacter pylori. Helicobacter. 2000;5:30-37.
36. Namiot DB, Namiot Z, Kemona A, et al. Dental status and efficacy of Helicobacter pylori eradication. Pol Arch Med Wewn. 2001;105:291-295.
37. Kignel S, de Almeida Pina F, Andre EA, et al. Occurrence of Helicobacter pylori in dental plaque and saliva of dyspeptic patients. Oral Dis. 2005;11:17-21.
38. Dore-Davin C, Heitz M, Yang H, et al. Helicobacter pylori in the oral cavity reflects handling of contaminants but not gastric infection. Digestion. 1999;60:196-202.
39. Krajden S, Fuksa M, Anderson J, et al. Examination of human stomach biopsies, saliva, and dental plaque for Campylobacter pylori. J Clin Microbiol. 1989;27:1397-1398.
40. Shames B, Krajden S, Fuksa M, et al. Evidence for the occurrence of the same strain of Campylobacter pylori in the stomach and dental plaque. J Clin Microbiol. 1989;27:2849-2850.
41. Banatvala N, Lopez CR, Owen R, et al. Helicobacter pylori in dental plaque. Lancet. 1993;341:380.
42. Semino-Mora C, Doi SQ, Marty A, et al. Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. J Infect Dis. 2003;187:1165-1177.
43. Siavoshi F, Salmanian AH, Akbari F, et al. Detection of Helicobacter pylori-specific genes in the oral yeast. Helicobacter. 2005;10:318-322.